YU791A - AZAOKSINDOL DERIVATIVES - Google Patents

AZAOKSINDOL DERIVATIVES

Info

Publication number
YU791A
YU791A YU791A YU791A YU791A YU 791 A YU791 A YU 791A YU 791 A YU791 A YU 791A YU 791 A YU791 A YU 791A YU 791 A YU791 A YU 791A
Authority
YU
Yugoslavia
Prior art keywords
derivatives
azaoksindol
diseases
inflammatory
azooxindole
Prior art date
Application number
YU791A
Other languages
Serbo-Croatian (sh)
Other versions
YU47728B (en
Inventor
R.P. Robinson
A. Marfat
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU791A publication Critical patent/YU791A/en
Publication of YU47728B publication Critical patent/YU47728B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Opisani su azaoksindol derivati, bliže rečeno novi 4-, 5-, 6-, i 7-azaoksindol derivati, jedinjenja koja su antiinflamatorna i analgetička sredstva i inhibitori jedne ili više od prostaglandin H2 sintaze, 5-lipoksigenaze i interleukin-1 biosinteza, koja se upotrebljavaju za tretiranje hroničnih inflamatornih oboljenja, alergije, psorijaze, različitih oboljenja kostiju, i imunih disfunkcija kao što je sistemski lupus erithematozis.Described are azooxindole derivatives, in particular novel 4-, 5-, 6-, and 7-azaoxindole derivatives, compounds that are anti-inflammatory and analgesic agents, and inhibitors of one or more of prostaglandin H2 synthase, 5-lipoxygenase, and interleukin-1 biosynthesis, which are used to treat chronic inflammatory diseases, allergies, psoriasis, various bone diseases, and immune dysfunctions such as systemic lupus erythematosus.

YU791A 1990-01-05 1991-01-04 AZAOKSINDOL DERIVATIVES YU47728B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1990/000107 WO1991009598A1 (en) 1990-01-05 1990-01-05 Azaoxindole derivatives

Publications (2)

Publication Number Publication Date
YU791A true YU791A (en) 1994-01-20
YU47728B YU47728B (en) 1996-01-08

Family

ID=22220612

Family Applications (1)

Application Number Title Priority Date Filing Date
YU791A YU47728B (en) 1990-01-05 1991-01-04 AZAOKSINDOL DERIVATIVES

Country Status (19)

Country Link
EP (1) EP0436333A3 (en)
JP (1) JPH0826018B2 (en)
KR (1) KR930005447B1 (en)
CN (1) CN1031053C (en)
AU (1) AU635593B2 (en)
BR (1) BR9100046A (en)
CA (1) CA2033531C (en)
CS (1) CS991A2 (en)
FI (1) FI922347A0 (en)
IE (1) IE910022A1 (en)
IL (1) IL96819A0 (en)
MY (1) MY109722A (en)
NO (1) NO922634L (en)
NZ (1) NZ236582A (en)
PL (2) PL166512B1 (en)
PT (1) PT96411B (en)
WO (1) WO1991009598A1 (en)
YU (1) YU47728B (en)
ZA (1) ZA9172B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
US5618819A (en) * 1994-07-07 1997-04-08 Adir Et Compagnie 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds
FR2722195B1 (en) * 1994-07-07 1996-08-23 Adir NOVEL 1,3-DIHYDRO-2H-PYRROLO (2,3-B) PYRIDIN-2-ONES AND OXAZOLO (4,5-B) PYRIDIN-2 (3H) -ONES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS WHO CONTAIN THEM
FR2722196B1 (en) * 1994-07-07 1996-08-23 Adir NOVEL AMINO DERIVATIVES OF 1,3-DIHYDRO-2H-PYRROLO (2,3-B) PYRIDIN-2-ONES AND OXAZOLO (4,5-B) PYRIDIN-2 (3H) -ONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS PHARMACEUTICAL CONTAINING THEM
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
KR20010101266A (en) 1998-12-17 2001-11-14 프리돌린 클라우스너, 롤란드 비. 보레르 4-aryloxindoles as inhibitors of jnk protein kinases
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
JP2002532503A (en) 1998-12-17 2002-10-02 エフ．ホフマン−ラ ロシュ アーゲー 4,5-Pyrazinooxindole as a protein kinase inhibitor
WO2000035908A1 (en) * 1998-12-17 2000-06-22 F. Hoffmann-La Roche Ag 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
JP2003518123A (en) 1999-12-21 2003-06-03 スージェン・インコーポレーテッド 4-Substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
DE10053275A1 (en) * 2000-10-27 2002-05-02 Dresden Arzneimittel New 7-aza-indole-3-carboxamides or glyoxylamides, useful e.g. for treating rheumatoid arthritis, osteoporosis, sepsis, asthma or multiple sclerosis are phosphodiesterase-4 and tumor necrosis factor-alpha inhibitors
TWI262920B (en) 2000-10-27 2006-10-01 Elbion Ag New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
US7291630B2 (en) * 2002-03-28 2007-11-06 Eisai Co., Ltd. Azaindoles as inhibitors of c-Jun N-terminal kinases
KR20070034049A (en) 2004-06-09 2007-03-27 글락소 그룹 리미티드 Pyrrolopyridine derivatives
US7906528B2 (en) * 2004-10-05 2011-03-15 Novartis International Pharmaceutical Ltd. Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
WO2009147476A1 (en) * 2008-06-02 2009-12-10 Matrix Laboratories Ltd. Novel pde inhibitors, pharmaceutical compositions containing them and processes for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
DE3681358D1 (en) * 1985-07-09 1991-10-17 Pfizer SUBSTITUTED OXINDOL-3-CARBOXAMINE AS AN ANTI-INFLAMMATORY AND PAIN-RELEASING AGENT.
WO1989012637A1 (en) * 1988-06-14 1989-12-28 Schering Corporation Heterobicyclic compounds having antiinflammatory activity

Also Published As

Publication number Publication date
PT96411A (en) 1991-10-15
FI922347A (en) 1992-05-22
JPH04210981A (en) 1992-08-03
AU6860691A (en) 1992-03-05
IE910022A1 (en) 1991-07-17
CS991A2 (en) 1991-09-15
EP0436333A2 (en) 1991-07-10
PL288598A1 (en) 1991-12-02
JPH0826018B2 (en) 1996-03-13
EP0436333A3 (en) 1992-05-27
NZ236582A (en) 1993-10-26
YU47728B (en) 1996-01-08
CA2033531C (en) 1998-06-23
AU635593B2 (en) 1993-03-25
PL165653B1 (en) 1995-01-31
KR930005447B1 (en) 1993-06-22
IL96819A0 (en) 1991-09-16
FI922347A0 (en) 1992-05-22
PT96411B (en) 1999-04-30
CA2033531A1 (en) 1991-07-06
CN1031053C (en) 1996-02-21
PL166512B1 (en) 1995-05-31
ZA9172B (en) 1992-10-28
NO922634D0 (en) 1992-07-03
BR9100046A (en) 1991-10-22
KR910014375A (en) 1991-08-31
CN1053065A (en) 1991-07-17
WO1991009598A1 (en) 1991-07-11
MY109722A (en) 1997-05-31
NO922634L (en) 1992-07-03

Similar Documents

Publication Publication Date Title
YU791A (en) AZAOKSINDOL DERIVATIVES
AR002267A1 (en) IMIDAZOLE COMPOUNDS USEFUL FOR THE TREATMENT OF PATHOLOGIES MEDIATED BY CYTOKINES; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; PROCESS TO PREPARE SUCH COMPOUNDS; USE OF THE SAME TO PREPARE SUCH COMPOSITIONS; INTERMEDIATE COMPOUNDS AND PROCESSES FOR ITS PREPARATION.
YU6602A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
YU64701A (en) Compounds useful as anti-inflamatory agents
NO20032254L (en) Compounds for Inhibition of Expression of VACM-I
DE60027016D1 (en) USE OF CONJUGATED LINOL ATTACHMENTS FOR THE TOPIC TREATMENT OF CELLULITIS
YU44398A (en) Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
DE68905863T2 (en) COMPOSITIONS OF ESSENTIAL FATTY ACIDS.
ATE215366T1 (en) TOPICAL COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASES
MXPA05005314A (en) Novel lapachone compounds and methods of use thereof.
YU47100A (en) Novel dihydroxahexanoic acid derivatives
ES2138595T3 (en) CYTOKIN INHIBITORS.
DE60129132D1 (en) INHIBITORS OF ALPHA-L BETA-2 MEDIATED CELL ADHESION
NO20003868D0 (en) Hydroxamic and carboxylic acid derivatives
CA1270834C (en) Substituted dihydrobenzopyrans
ES2150705T3 (en) USEFUL STEROID NITRITE ESTER DERIVATIVES AS ANTI-INFLAMMATORY PHARMACES.
BR0309386A (en) Triaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinases inhibitors
DE69525740T2 (en) Special compositions containing halofantrine
DK0727996T3 (en) Fendazole formulations
MXPA03007413A (en) Composition and method for treating inflammatory disorders.
FI950842A (en) Novel 2-substituted tricyclic indan-2-mercaptoacetylamide derivatives useful as enkephalinase inhibitors
ES2056983T3 (en) COMPOUNDS TO INHIBIT THE BIOSYNTHESIS OF METABOLITES OF ARACHIDONIC ACID DERIVED FROM LIPOXIGENASE.
PT841933E (en) BOWMAN-BIRK INHIBITOR COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES
CO4920227A1 (en) HISTIDINA-N-BENCIL GLICINAMIDA SUBSTITUTED WITH CYCLLOALKYL.